Astec Lifesciences Reports Financial Struggles Amid Declining Sales and Rising Costs in April 2025

Apr 24 2025 10:45 AM IST
share
Share Via
Astec Lifesciences has reported its financial results for the quarter ending March 2025, revealing significant challenges. Net sales reached Rs 119.53 crore, with both Profit Before Tax and Profit After Tax showing considerable losses. Additionally, interest expenses increased, indicating rising borrowing costs amid ongoing financial pressures.
Astec Lifesciences, a small-cap player in the Pesticides & Agrochemicals industry, has reported its financial results for the quarter ending March 2025 on April 23, 2025. The company has experienced notable challenges in its financial performance during this period.

The net sales for the quarter stood at Rs 119.53 crore, reflecting a significant decline compared to the same quarter last year. This downward trend in sales is indicative of broader issues affecting the company's revenue generation capabilities. Additionally, the Profit Before Tax (PBT), excluding other income, reported a loss of Rs 16.45 crore, marking a substantial year-on-year decline. Similarly, the Profit After Tax (PAT) also showed a considerable loss of Rs 16.09 crore, further emphasizing the financial difficulties faced by Astec Lifesciences.

On a different note, the interest expense over the latest six months has shown an increase, amounting to Rs 20.32 crore, which suggests a rise in borrowing costs for the company. This adjustment in evaluation reflects the ongoing financial pressures that Astec Lifesciences is navigating.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News